197 related articles for article (PubMed ID: 25110949)
1. Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis.
Ortega-Madueño I; Garcia-Montojo M; Dominguez-Mozo MI; Garcia-Martinez A; Arias-Leal AM; Casanova I; Arroyo R; Alvarez-Lafuente R
PLoS One; 2014; 9(8):e104836. PubMed ID: 25110949
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
Domínguez-Mozo MI; Nieto-Guerrero A; Pérez-Pérez S; García-Martínez MÁ; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2020; 11():2142. PubMed ID: 33072077
[TBL] [Abstract][Full Text] [Related]
3. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
Pérez-Pérez S; Domínguez-Mozo MI; García-Martínez MÁ; García-Frontini MC; Villarrubia N; Costa-Frossard L; Villar LM; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2021; 12():798003. PubMed ID: 34912348
[TBL] [Abstract][Full Text] [Related]
4. Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients.
Pérez-Pérez S; Cuello JP; Martínez-Ginés M; Pardo-Rodríguez B; García-Domínguez JM; Domínguez-Mozo MI; Lozano-Ros A; García-Martínez MÁ; Higueras Y; Meldaña-Rivera A; Goicochea-Briceño H; Tejeda-Velarde A; Fernández-Velasco JI; Medina S; Arroyo R; Villar LM; Álvarez-Lafuente R
Sci Rep; 2021 Apr; 11(1):8441. PubMed ID: 33875702
[TBL] [Abstract][Full Text] [Related]
5. HHV-6 A- or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum.
Xu Y; Linde A; Fredrikson S; Dahl H; Winberg G
J Med Virol; 2002 Mar; 66(3):394-9. PubMed ID: 11793393
[TBL] [Abstract][Full Text] [Related]
6. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
Dominguez-Mozo MI; Perez-Perez S; Villar LM; Oliver-Martos B; Villarrubia N; Matesanz F; Costa-Frossard L; Pinto-Medel MJ; García-Sánchez MI; Ortega-Madueño I; Lopez-Lozano L; Garcia-Martinez A; Izquierdo G; Fernández Ó; Álvarez-Cermeño JC; Arroyo R; Alvarez-Lafuente R
Sci Rep; 2020 Aug; 10(1):14244. PubMed ID: 32859922
[TBL] [Abstract][Full Text] [Related]
8. HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
Engdahl E; Gustafsson R; Ramanujam R; Sundqvist E; Olsson T; Hillert J; Alfredsson L; Kockum I; Fogdell-Hahn A
Hum Immunol; 2014 Jun; 75(6):524-30. PubMed ID: 24662416
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis.
Nielsen L; Larsen AM; Munk M; Vestergaard BF
Acta Neurol Scand Suppl; 1997; 169():76-8. PubMed ID: 9174642
[TBL] [Abstract][Full Text] [Related]
10. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.
Ablashi DV; Eastman HB; Owen CB; Roman MM; Friedman J; Zabriskie JB; Peterson DL; Pearson GR; Whitman JE
J Clin Virol; 2000 May; 16(3):179-91. PubMed ID: 10738137
[TBL] [Abstract][Full Text] [Related]
11. Evidence of active herpesvirus 6 (variant-A) infection in patients with lymphadenopathy in Belém, Pará, Brazil.
Freitas RB; Freitas MR; Linhares AC
Rev Inst Med Trop Sao Paulo; 2003; 45(5):283-8. PubMed ID: 14743669
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of viral antibodies in Iranian multiple sclerosis patients.
Khaki M; Ghazavi A; Ghasami K; Rafiei M; Payani MA; Ghaznavi-Rad E; Mosayebi G
Neurosciences (Riyadh); 2011 Jul; 16(3):224-8. PubMed ID: 21677611
[TBL] [Abstract][Full Text] [Related]
13. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients.
Ongrádi J; Rajda C; Maródi CL; Csiszár A; Vecsei L
J Neurovirol; 1999 Oct; 5(5):529-32. PubMed ID: 10568890
[TBL] [Abstract][Full Text] [Related]
14. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.
Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
Front Immunol; 2019; 10():2715. PubMed ID: 32038605
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis.
Behzad-Behbahani A; Mikaeili MH; Entezam M; Mojiri A; Pour GY; Arasteh MM; Rahsaz M; Banihashemi M; Khadang B; Moaddeb A; Nematollahi Z; Azarpira N
J Microbiol Immunol Infect; 2011 Aug; 44(4):247-51. PubMed ID: 21524958
[TBL] [Abstract][Full Text] [Related]
16. MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Dominguez-Mozo MI; Garcia-Montojo M; De Las Heras V; Garcia-Martinez A; Arias-Leal AM; Casanova I; Arroyo R; Alvarez-Lafuente R
BMC Neurol; 2012 Sep; 12():107. PubMed ID: 23009575
[TBL] [Abstract][Full Text] [Related]
17. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls.
Enbom M; Wang FZ; Fredrikson S; Martin C; Dahl H; Linde A
Clin Diagn Lab Immunol; 1999 Jul; 6(4):545-9. PubMed ID: 10391860
[TBL] [Abstract][Full Text] [Related]
18. Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.
Virtanen JO; Färkkilä M; Multanen J; Uotila L; Jääskeläinen AJ; Vaheri A; Koskiniemi M
J Neurovirol; 2007 Aug; 13(4):347-52. PubMed ID: 17849318
[TBL] [Abstract][Full Text] [Related]
19. Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort:
Domínguez-Mozo MI; González-Suárez I; Villar LM; Costa-Frossard L; Villarrubia N; Aladro Y; Pilo B; Montalbán X; Comabella M; Casanova-Peño I; Martínez-Ginés ML; García-Domínguez JM; García-Martínez MÁ; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2023; 14():1248182. PubMed ID: 37841253
[TBL] [Abstract][Full Text] [Related]
20. [Level of HHV-6A antibodies in symptomless HIV infection as well as in the course of AIDS].
Ongrádi J; Bánhegyi D; Maródi CL; Nagy K; Csiszár A; Horváth A
Orv Hetil; 1999 Aug; 140(34):1881-5. PubMed ID: 10502970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
